These Analysts Revise Their Forecasts On Abbott Following Q2 Results

benzinga.com/analyst-stock-ratings/price-target/25/07/46491034/these-analysts-revise-their-forecasts-on-abbott-following-q2-results

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but dialed back earnings and growth projections for the rest of the year.
The company reported second-quarter sales of $11.14 billion, beating the consensus of $11.07 billion. The U.S.…

This story appeared on benzinga.com, 2025-07-18 13:03:05.
The Entire Business World on a Single Page. Free to Use →